Showing results (151-160 of 196) with videos related to

Sort By:
Pageof 20
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 5, 2013
Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseasesKeiichi Masaki, Shintaro Takaki, Hideyuki Hyogo, et al.
Journal of Viral Hepatitis|July 13, 2018
CTL-associated and NK cell-associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patientsMotonobu Nomura, Masataka Tsuge, Takuro Uchida, et al.
Cancers|May 16, 2023
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-FetoproteinTakahiro Kinami, Kei Amioka, Tomokazu Kawaoka, et al.
Communications Medicine|October 25, 2023
Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinomaMasami Yamauchi, Atsushi Ono, Kei Amioka, et al.
Liver Cancer|May 12, 2021
Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal VeinYumi Kosaka, Tomoki Kimura, Tomokazu Kawaoka, et al.
Cancers|February 11, 2023
Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma-Consideration of the Locations of Target LesionsShigeki Yano, Tomoki Kimura, Tomokazu Kawaoka, et al.
Cancers|November 25, 2023
Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular CarcinomaShigeki Yano, Tomokazu Kawaoka, Shintaro Yamasaki, et al.
DEN Open|April 18, 2025
Analysis of the treatment outcome of duodenal varices: A retrospective case series of 15 patients from a single institutionYuri Mitamura, Eisuke Murakami, Ko Hashimoto, et al.
Internal Medicine (Tokyo, Japan)|July 1, 2021
Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with SorafenibKenji Yamaoka, Tomokazu Kawaoka, Hiroshi Aikata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 22, 2018
Comparison of hepatic arterial infusion chemotherapy between 5-fluorouracil-based continuous infusion chemotherapy and low-dose cisplatin monotherapy for advanced hepatocellular carcinomaTomokazu Kawaoka, Hiroshi Aikata, Tomoki Kobayashi, et al.
Pageof 20